2005Journal watchRequires access

WOMEN’S HEALTH INITIATIVE UPDATE: Surprise! Menopausal Symptoms Return After Stopping HT

Jane E. Corboy

Open publisher page 0 citations

Abstract

This is another report from the discontinued, estrogen-progestin arm of the WHI's hormone therapy trial. In this arm, 16,608 postmenopausal women who had not had hysterectomy were randomized to receive either conjugated estrogens (0.625 mg/day) plus medroxyprogesterone acetate (2.5 mg/day) or placebo (Journal Watch Women's Health Aug 7 2002). Clinicians are well aware that menopausal symptoms are likely to return in women who discontinue HT, but which …

About this research paper

What this paper is about

This is another report from the discontinued, estrogen-progestin arm of the WHI's hormone therapy trial. In this arm, 16,608 postmenopausal women who had not had hysterectomy were randomized to receive either conjugated estrogens (0.625 mg/day) plus medroxyprogesterone acetate (2.5 mg/day) or placebo (Journal Watch Women's Health Aug 7 2002). Clinicians are well aware that menopausal symptoms are likely to return in women who discontinue HT, but which …

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This is another report from the discontinued, estrogen-progestin arm of the WHI's hormone therapy trial. In this arm, 16,608 postmenopausal women who had not had hysterectomy were randomized to receive either conjugated estrogens (0.625 mg/day) plus medroxyprogesterone acetate (2.5 mg/day) or placebo (Journal Watch Women's Health Aug 7 2002). Clinicians are well aware that menopausal symptoms are likely to return in women who discontinue HT, but which …

Key concepts: Medroxyprogesterone acetate, Medicine, Women's Health Initiative, Progestin, Placebo, Hormone therapy, Estrogen, Medroxyprogesterone

Related papers

Back to paper searchBrowse research topicsOriginal source
WOMEN’S HEALTH INITIATIVE UPDATE: Surprise! Menopausal Symptoms Return After Stopping HT — Research Paper | ScholarLens